7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Acromegaly D000172 6 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Actinomycosis D000196 2 associated lipids
Addison Disease D000224 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Angina, Unstable D000789 14 associated lipids
Angioid Streaks D000793 1 associated lipids
Ankylosis D000844 1 associated lipids
Aortic Diseases D001018 11 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Atresia D001656 4 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Bone Neoplasms D001859 5 associated lipids
Bone Resorption D001862 7 associated lipids
Cachexia D002100 21 associated lipids
Calcinosis D002114 5 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Carcinosarcoma D002296 7 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Celiac Disease D002446 16 associated lipids
Brain Ischemia D002545 89 associated lipids
Cherubism D002636 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Chronic Disease D002908 7 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Crohn Disease D003424 12 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dengue D003715 2 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Dermatomyositis D003882 2 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Diarrhea D003967 32 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Disease Susceptibility D004198 12 associated lipids
Emphysema D004646 1 associated lipids
Encephalitis D004660 15 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Endometriosis D004715 29 associated lipids
Eye Neoplasms D005134 2 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Gingival Recession D005889 2 associated lipids
Glioma D005910 112 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Graves Disease D006111 6 associated lipids
Heart Failure D006333 36 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Hemarthrosis D006395 1 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Hemophilia A D006467 10 associated lipids
Hepatitis C D006526 7 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hip Dislocation D006617 1 associated lipids
Hip Fractures D006620 2 associated lipids
Hirsutism D006628 3 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperinsulinism D006946 27 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypocalcemia D006996 12 associated lipids
Hypothyroidism D007037 32 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Zang L et al. The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. 2015 Sci Rep pmid:26671549
Liu W et al. Polymorphisms in three genes are associated with hemorrhagic stroke. 2015 Brain Behav pmid:26664786
Widschwendter M et al. Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. 2015 EBioMedicine pmid:26629528
Rachner TD and Rauner M RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers. 2015 EBioMedicine pmid:26629502
Niu Y et al. Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. 2015 BMC Endocr Disord pmid:26626139
Miao Q et al. Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway. 2015 Int J Clin Exp Pathol pmid:26617755
Goswami S and Sharma-Walia N Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. 2015 BMC Cancer pmid:26608463
Li CW et al. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. 2015 Genet. Mol. Res. pmid:26345854
Pan X et al. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. 2015 PLoS ONE pmid:26334877
Wang B et al. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. 2015 Sci Rep pmid:26329493
Ostrowska Z et al. Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2015 Endokrynol Pol pmid:26323468
Kulcsar-Jakab E et al. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. 2015 BMC Musculoskelet Disord pmid:26311162
Silva Vde O et al. β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. 2015 PLoS ONE pmid:26291983
Darabi H et al. Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. 2015 Medicine (Baltimore) pmid:26287420
Gennaro G et al. Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats. 2015 PLoS ONE pmid:26270535
Niu Y et al. Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes. 2015 BMC Cardiovasc Disord pmid:26260869
Marley K et al. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL. 2015 Exp. Cell Res. pmid:26254896
McCarthy NI et al. Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development. 2015 J. Immunol. pmid:26254339
Fernández-González FJ et al. Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. 2015 Dental Press J Orthod pmid:26560822
Burton LJ et al. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. 2015 Carcinogenesis pmid:26069256
Collins FL et al. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. 2015 J Immunol Res pmid:26065008
Zavala-Cerna MG et al. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. 2015 J Immunol Res pmid:26065000
Davenport C et al. The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes. 2015 J Diabetes Res pmid:26064990
Rzepka R et al. Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. 2015 BMC Pregnancy Childbirth pmid:26059227
Weichhaus M et al. Osteoprotegerin in breast cancer: beyond bone remodeling. 2015 Mol. Cancer pmid:26054853
Kastritis E et al. Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. 2015 Blood Cancer J pmid:26047389
Janda K et al. Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. 2015 BMC Nephrol pmid:26037625
Davenport C et al. The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes. 2015 Eur. J. Endocrinol. pmid:26036811
Harrison R et al. Acute bone response to whole body vibration in healthy pre-pubertal boys. 2015 J Musculoskelet Neuronal Interact pmid:26032203
Goyden J et al. The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. 2015 PLoS ONE pmid:26030441
Beederman M et al. Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. 2015 Plast. Reconstr. Surg. pmid:26017615
Tanaka Y et al. [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. 2015 Nihon Rinsho Meneki Gakkai Kaishi pmid:26016635
Zhao L et al. Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. 2015 J. Nutr. Biochem. pmid:26239832
Tsuruda T Osteoprotegerin: osteo-vascular connection. 2015 J. Atheroscler. Thromb. pmid:25740050
Shah M et al. Local origins impart conserved bone type-related differences in human osteoblast behaviour. 2015 Eur Cell Mater pmid:25738584
Alwood JS et al. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue. 2015 J. Interferon Cytokine Res. pmid:25734366
Xiong L et al. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:25733894
Qiao B et al. Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. 2015 Drug Des Devel Ther pmid:25733814
Choe CH et al. Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. 2015 FEBS Lett. pmid:25728277
de Molon RS et al. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. 2015 J. Bone Miner. Res. pmid:25727550
Nagy V and Penninger JM The RANKL-RANK Story. 2015 Gerontology pmid:25720990
Han J et al. [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. 2015 Beijing Da Xue Xue Bao pmid:25686326
Yang X et al. Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. 2015 ScientificWorldJournal pmid:25685846
Chung CP et al. A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. 2015 Int J Mol Sci pmid:25679449
Kuroyanagi G et al. Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. 2015 Mol Med Rep pmid:26044505
Lee CJ et al. Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. 2015 J. Atheroscler. Thromb. pmid:25318352
Maser RE et al. Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes. 2015 Endocr Pract pmid:25100392
Potocka-Bakłażec M et al. Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis. 2015 Eur Arch Otorhinolaryngol pmid:24676726
Kelesidis T et al. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. 2014 Jul-Sep AIDS Rev pmid:25102334
Bastos MF et al. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. 2014 Jan-Feb Int J Oral Maxillofac Implants pmid:24451874

Table of Content